CLADRIBINA ( DrugBank: Cladribina )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	9

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003995-42-IT (EUCTR)	13/05/2021	04/06/2021	Extension to the MAGNIFY MS trial on Mavenclad®	A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have ...	Highly-active relapsing multiple sclerosis MedDRA version: 21.1;Level: PT;Classification code 100633 ...	Trade Name: MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE Product Name: C ...	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	261	Phase 4	Hungary;Czech Republic;Canada;Finland;Poland;Australia;Israel;Germany;Italy
2	EUCTR2020-003874-30-IT (EUCTR)	08/01/2021	24/05/2021	Cognition and HRQoL in adults with highly-active RMS in Year 3 and 4 after initial Mavenclad® dose	A 2-year follow-up study to assess cognition and health-related quality of life in participants with ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE Product Name: C ...	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 4	France;Czechia;Hungary;Slovakia;Spain;Poland;Denmark;Austria;Netherlands;Italy
3	EUCTR2019-000069-19-IT (EUCTR)	11/10/2019	01/09/2021	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Multiple Sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029205;Term: Nervous system ...	Trade Name: MAVENCLAD Product Name: Cladribina Product Code: [Not applicable]	MERCK KGAA	NULL	Not Recruiting			Female: yes Male: yes	1000	Phase 4	United States;Portugal;Estonia;Morocco;Greece;Spain;Ukraine;Lebanon;Russian Federation;Switzerland;I ...
4	EUCTR2017-002631-42-IT (EUCTR)	16/07/2018	17/06/2021	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Mavenclad Product Code: [-] INN or Proposed INN: CLADRIBINA Other d ...	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	265	Phase 4	Czechia;Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic; ...
5	EUCTR2017-002632-17-IT (EUCTR)	03/05/2018	22/01/2021	A Quality of Life Study for People with Relapsing Multiple Sclerosis	A 2-year Prospective Study to Assess Health-related Quality of Life in Subjects with Highly-Active R ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Mavenclad Product Code: [.] INN or Proposed INN: CLADRIBINA	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	445	Phase 4	Portugal;Czechia;Slovakia;Greece;Finland;Spain;Ireland;Lithuania;Austria;United Kingdom;Italy;France ...
6	EUCTR2009-017978-21-ES (EUCTR)	13/07/2011	17/11/2011	Long-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinica ...	Prospective observational long-term safety registry of Multiple Sclerosis patients who have particip ...	Pacientes con esclerosis múltiple que hayan participado en estudios con cladribina. MedDRA version: ...	Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN: Cladribine Other des ...	Merck Serono S.A. - Geneva	NULL	Not Recruiting			Female: yes Male: yes	2175	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Serbia;Portugal;United Arab Emirates;United States;Estonia;Taiwan;Saudi Arabia;Morocco;Greece;Thaila ...
7	EUCTR2008-003706-33-ES (EUCTR)	29/01/2009	09/12/2008	A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladri ...	A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladri ...	Subjects with a first clinical demyelinating event (Clinically Isolated Syndrome (CIS)) at high risk ...	Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: 2-chloro-2?-deoxy-ß-D ...	Merck Serono International	NULL	Not Recruiting			Female: yes Male: yes	642	Phase 3	Portugal;Germany;Bulgaria;Norway;France;Italy;Austria;Sweden;Finland;Czech Republic;United Kingdom;B ...
8	EUCTR2007-000381-20-IT (EUCTR)	29/05/2008	20/03/2008	na	VEDI ITALIANO - CLARITY EXTENTION	SCLEROSI MULTIPLA A RICADUTE E REMISSIONI MedDRA version: 14.1;Level: PT;Classification code 1002824 ...	Product Name: CLADRIBINA Product Code: NA INN or Proposed INN: Cladribine	MERCK SERONO SA	NULL	Not Recruiting			Female: yes Male: yes	1100		Portugal;Estonia;Greece;Finland;Lithuania;Austria;Italy;United Kingdom;France;Czech Republic;Denmark ...
9	EUCTR2006-003366-33-ES (EUCTR)	13/02/2007	03/03/2010	Estudio multicéntrico en fase II, aleatorizado, doble ciego y controlado frente a placebo, de seguri ...	Estudio multicéntrico en fase II, aleatorizado, doble ciego y controlado frente a placebo, de seguri ...	Pacientes con esclerosis múltiple activa MedDRA version: 9.0;Level: PT;Classification code 10028245	Trade Name: not applicable Product Name: Interferon beta-1a FBS-free/HSA free, RNF Product Code: Not a ...	Serono International, S.A.	NULL	Not Recruiting			Female: yes Male: yes	290	Phase 2	Spain;Italy

First Previous1Next Last